SCHEMBL712924

SCHEMBL712924

OCC1(CO)OCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL711113 0.87 KDM4E (0.39)
SCHEMBL8933487 0.82
SCHEMBL714960 0.82
SCHEMBL712145 0.82
SCHEMBL14445092 0.76
SCHEMBL22292115 0.76 HSD11B1 (0.34)
SCHEMBL744998 0.73
SCHEMBL714207 0.72 KDM4E (0.34)
SCHEMBL712029 0.72 KDM4E (0.34)
SCHEMBL16692491 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036672-A 1, 3-Dioxane hydrocarbon-2, 2-dimethanol diester compound and preparation method and application thereof 中国石油化工股份有限公司 2026-05-15 CN claimed
CN-122037003-A Catalyst component for olefin polymerization, catalyst and application thereof, and olefin polymerization method 中国石油化工股份有限公司 2026-05-15 CN claimed
CN-122037014-A Catalyst component for olefin polymerization, catalyst and application thereof, and olefin polymerization method 中国石油化工股份有限公司 2026-05-15 CN claimed
CN-122037008-A Catalyst component for olefin polymerization, catalyst and application thereof, and olefin polymerization method 中国石油化工股份有限公司 2026-05-15 CN claimed
EP-3641826-A1 METHODS OF PRODUCING DRUG-CARRYING POLYMER SCAFFOLDS AND PROTEIN-POLYMER-DRUG CONJUGATES Mersana Therapeutics, Inc. (US) 2020-04-29 EP claimed
WO-2018237262-A1 METHODS OF PRODUCING DRUG-CARRYING POLYMER SCAFFOLDS AND PROTEIN-POLYMER-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. (US) 2018-12-27 WO claimed
EP-2928503-A1 AURISTATIN COMPOUNDS AND CONJUGATES THEREOF Mersana Therapeutics, Inc. (US) 2015-10-14 EP claimed
WO-2014093379-A1 AURISTATIN COMPOUNDS AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. (US) 2014-06-19 WO claimed
EP-2459224-A2 BLOOD COAGULATION PROTEIN CONJUGATES Baxter International Inc (US) 2012-06-06 EP claimed
WO-2011017055-A2 BLOOD COAGULATION PROTEIN CONJUGATES BAXTER INTERNATIONAL INC. (US) 2011-02-10 WO claimed
WO-2005070386-A1 BODY ART THE DEZAC GROUP LIMITED (GB) 2005-08-04 WO claimed
CN-1562997-A 1,3-dioxolane-2,2-dimethylalcohol, preparation method and usage UNIV WUHAN (CN) 2005-01-12 CN claimed
US-20030108495-A1 Cosmetic compositions containing 2,2-dihydroxymethy1-1,3-dioxolanes STROUD ERIC MATTHEW (US) 2003-06-12 US claimed
CN-122037014-A Catalyst component for olefin polymerization, catalyst and application thereof, and olefin polymerization method 中国石油化工股份有限公司 2026-05-15 CN disclosed
CN-122037003-A Catalyst component for olefin polymerization, catalyst and application thereof, and olefin polymerization method 中国石油化工股份有限公司 2026-05-15 CN disclosed
CN-122036672-A 1, 3-Dioxane hydrocarbon-2, 2-dimethanol diester compound and preparation method and application thereof 中国石油化工股份有限公司 2026-05-15 CN disclosed
US-20030108495-A1 Cosmetic compositions containing 2,2-dihydroxymethy1-1,3-dioxolanes STROUD ERIC MATTHEW (US) 2003-06-12 US disclosed
US-20020187281-A1 Chiral additives for cholesteric displays KENT DISPLAYS, INC. 2002-12-12 US disclosed
WO-2001096494-A1 CHIRAL ADDITIVES FOR CHOLESTERIC DISPLAYS KENT DISPLAYS, INC. (US) 2001-12-20 WO disclosed
EP-0808824-A2 Process for preparing optically active 2-halogeno-3-hydroxypropionic acid ester TANABE SEIYAKU CO., LTD. (JP) 1997-11-26 EP disclosed